On Friday, July 13, California’s Office of Statewide Health Planning and Development (OSHPD) posted for public comment (available here) its official rulemaking package for implementing Senate Bill 17 in California.
California’s Proposition 65 requires businesses to provide warnings with products or at facilities if they contain any chemicals (out of a list of around 900) at levels above specified safe harbor levels.
The history of local take back measures in California has mostly focused around the heavily populated Counties near the Pacific Coast. Now, with the passage of a take back ordinance in rural Tehama County, the issue has moved inland.
According to Kaiser Health News, patients overpay for prescriptions 23% of the time. Check out CLSA’s infographic calling for more accountability of Pharmacy Benefit Managers (PBMs).
The California Legislature voted to approve a budget deal on June 14 between Democratic legislators and Governor Jerry Brown, which will be his last budget as governor. The budget was passed hours prior to the June 15 at midnight deadline, includes several significant wins for the life sciences sector.
CLSA is proud to endorse the Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5997), bipartisan legislation that bridges Medicare patient access gaps and modernizes policies to allow coverage of medical technologies approved through FDA’s expedited review process.
CLSA looks forward to working with Mayor-elect London Breed and her Administration to advance thoughtful policies that will grow and ensure the vibrancy of San Francisco’s treasured life sciences ecosystem.
CLSA is proud that hundreds of our innovative member companies call the Bay Area home, and we look forward to working with Mayor-elect London Breed and her Administration to advance thoughtful policies that will grow and ensure the vibrancy of San Francisco’s treasured life sciences ecosystem.
2018 – 2019 state budget includes $30 million for Precision Medicine Research
CLSA Pres & CEO Sara Radcliffe was recently featured in the San Diego Union-Tribune commenting on the entrepreneurial spirit and growth of San Diego’s biomedical sector, which is focused advancing new treatments for patients in need.